Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Florida for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Florida only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Florida (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Keye Wong (NPI 1164468211)

Field	Value
Entity Type	Individual
Organization	Keye Wong
Address	2601 Cattlemen Rd Ste 102
City	Sarasota
State	FL
ZIP	34232
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	June 20, 2006

Payer Source	Total Paid
Medicare	$4.9M
Medicaid	$0

Key Findings

KEYE WONG is a retina specialist (ophthalmology) with a long Medicare billing history—NPI enumerated ~20 years ago—indicating sustained participation in Medicare over multiple practice years. The provider's lifetime Medicare revenue on file is $4.9M and there is no Medicaid billing on file, making this effectively a single-payer (Medicare-focused) billing profile.

Revenue concentration is high: the three highest-revenue Medicare codes (J0178, J2777, J2778) together account for 79.7% of this provider's total Medicare revenue, indicating a practice centered on intravitreal biologic therapies rather than broad primary ophthalmology or multispecialty services. This concentration suggests the provider’s business model is heavily weighted toward anti-VEGF and related retinal injections.

The dominant single code is J0178 (aflibercept) with $2M revenue, representing 41.1% of total Medicare revenue; combined with J2777 (faricimab) at $1.6M (32.8%), these two therapeutic injection codes drive the majority of reimbursement and imply procedural throughput focused on intravitreal injections for retinal diseases. High average paid per claim for J0178 ($695) and the large claim counts (2.9K claims for J0178, 56K claims for J2777) further support a high-volume retinal injection practice.

Competitive standing on Medicare is strong for multiple procedural codes: the provider ranks in the top percentiles nationally for key retinal procedure and imaging codes—J0178 ranks in the 94th percentile (#194/3204), J2777 in the 96th percentile (#79/2039), 67028 in the 97th percentile (#111/4255), and 92134 and 92012 are extreme outliers at the 100th and 99th percentiles respectively. These rank/percentile positions indicate significantly higher than typical national volume for core retina services and diagnostic imaging.

Several imaging and evaluation codes show unusually high volumes relative to peers, reinforcing a full-service retinal practice: 92134 (retinal imaging) is an extreme outlier with 4.1K claims and $120.1K revenue, and 92012/92014 (established comprehensive/intermediate exams) also appear notably above typical national volume (92012 at the 99th percentile; 92014 at the 97th percentile). This mix indicates the provider delivers both high-volume therapeutic injections and substantial diagnostic follow-up and office-based eye care.

The provider shows limited diversification into non-injection drugs and ancillary procedures: codes like Q5128 (ranibizumab biosimilar) and J2778 (ranibizumab) contribute smaller but material shares ($232.2K and $286K respectively), while several unclassified drug codes (J3590, J3490, J7999) and less-frequent procedures appear at low revenue shares and modest national ranks. This suggests most revenue is concentrated in a few high-volume biologic injection products with smaller supplemental revenue streams.

Absence of Medicaid billing on file means there is no in-state Medicaid footprint to assess against peers, so conclusions about state-level payer mix or Medicaid competitiveness cannot be made; the provider operates, at least in the claims captured here, as effectively Medicare-only. This may reflect panel composition, payer contracting, or data coverage rather than clinical scope.

Operationally, the provider’s pattern—high volumes of intravitreal injections and related imaging/exam codes—implies a practice optimized for frequent, procedure-driven visits and serial therapeutic administration for retinal disease management (e.g., AMD, DME). Payers and analysts should interpret this as a high-throughput retina service line with clinical throughput concentrated in recurring injection encounters.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

21 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	2,930	$700	$2M
J2777	Injection, faricimab‑svoa, 0.1 mg	55,980	$30	$1.6M
J2778	Injection, ranibizumab, 0.1 mg	1,560	$180	$286K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	2,870	$90	$255.2K
Q5128	Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg	1,070	$220	$232.2K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	4,140	$30	$120.1K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	1,250	$90	$109K
92012	For this CPT code, an Ophthalmologist sees an established patient for an intermediate level eye examination. Generally, a patient is considered to be "established" if the same physician, or any…	1,450	$70	$94.4K
J3590	Unclassified biologics	50	$1,070	$54.7K
J3490	Unclassified drugs	30	$1,410	$35.2K

Showing 1–10 of 21

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 21 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Florida Distribution

Keye Wong — 4 of 21 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Florida

Full comparison — all codes billed, vs. state median

21 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	20	250	800	$690	$817.6K
J2777	10	170	12,810	$30	$549.2K
J2778	23	110	660	$180	$234.1K
Q5128	18	40	770	$220	$216.3K
J2781	45	50	500	$120	$102K
67028	16	300	710	$90	$91.1K
J3490	162	180	70	$280	$87.5K
J3590	3	20	30	$1,360	$50.3K
92014	120	2,180	160	$80	$28.5K
92012	25	1,170	110	$60	$16.7K

Showing 1–10 of 21

Related Providers

Other providers that share a Tax Identification Number (TIN) with Keye Wong, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Elia Mavrofrides	FL	Ophthalmology Physician	$6.2M	$240
Paul Raskauskas	FL	Retina Specialist (Ophthalmology) Physician	$5.2M	$0
Thomas Ward	FL	Retina Specialist (Ophthalmology) Physician	$4.7M	$0
Thomas Barnard	FL	Ophthalmology Physician	$4.5M	$6.5K
John Niffenegger	FL	Retina Specialist (Ophthalmology) Physician	$4.4M	$0
Samuel Houston	FL	Ophthalmology Physician	$4.2M	$39.3K
Matthew Cunningham	FL	Ophthalmology Physician	$4M	$1.8K
Elizabeth Richter	FL	Retina Specialist (Ophthalmology) Physician	$3.5M	$0
Jaya Kumar	FL	Ophthalmology Physician	$3.4M	$3K
Abdallah Jeroudi	FL	Ophthalmology Physician	$3.3M	$2.9K

Nearby Providers

Other providers in the same ZIP code as Keye Wong, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Family First Homecare, LLC	FL	Nursing Care Agency	$0	$52.5M
Neurointernational Healthcare, LLC	FL	Rehabilitation Hospital	$0	$34.9M
Andrew Marple	FL	Hematology & Oncology Physician	$3.2M	$0
Fadi Kayali	FL	Medical Oncology Physician	$2.9M	$0
Joe Kelley	FL	Rheumatology Physician	$2.6M	$0
Surgery Center At University Park, LLC	FL	Ambulatory Surgical Clinic/Center	$2.5M	$0
Hakim Morsli	FL	Cardiovascular Disease Physician	$2.1M	$0
Richard Buck	FL	Medical Oncology Physician	$2.1M	$0
Aesculapian Surgery Center, LLC	FL	Ambulatory Surgical Clinic/Center	$1.7M	$0
Edward Stolarski	FL	Adult Reconstructive Orthopaedic Surgery Physician	$1.7M	$0

Keye Wong — Billing Profile & Reimbursement Data

Sign up for Keye Wong — Billing Profile & Reimbursement Data policy alerts

Keye Wong — Billing Profile & Reimbursement Data

Sign up for Keye Wong — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References